Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) was upgraded by equities researchers at StockNews.com from a “hold” rating to a “buy” rating in a research note issued on Saturday.
Kewaunee Scientific Price Performance
Shares of NASDAQ:KEQU opened at $37.90 on Friday. The stock has a market cap of $108.85 million, a PE ratio of 6.08 and a beta of 0.73. The company’s fifty day moving average is $35.21 and its 200 day moving average is $41.50. Kewaunee Scientific has a 52 week low of $16.51 and a 52 week high of $55.62. The company has a quick ratio of 2.00, a current ratio of 2.53 and a debt-to-equity ratio of 0.48.
Kewaunee Scientific (NASDAQ:KEQU – Get Free Report) last issued its earnings results on Wednesday, September 11th. The technology company reported $0.93 EPS for the quarter. The company had revenue of $48.39 million for the quarter. Kewaunee Scientific had a net margin of 9.13% and a return on equity of 25.87%.
Institutional Investors Weigh In On Kewaunee Scientific
About Kewaunee Scientific
Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments, Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.
Featured Articles
- Five stocks we like better than Kewaunee Scientific
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Are Penny Stocks a Good Fit for Your Portfolio?
- Top-Performing Non-Leveraged ETFs This Year
- Stock Sentiment Analysis: How it Works
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Kewaunee Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kewaunee Scientific and related companies with MarketBeat.com's FREE daily email newsletter.